Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Documenti analoghi

• Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study
  di: Bailey, Swneke D., et al.
  Pubblicazione: (2010)
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
  di: Santaguida, P L, et al.
  Pubblicazione: (2005)
• Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
  di: Grant, Suzanne J, et al.
  Pubblicazione: (2009)
• Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
  di: Zhang, Fang, et al.
  Pubblicazione: (2012)
• Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study
  di: Lorenzo, Carlos, et al.
  Pubblicazione: (2013)